Ligand Pro, founded by Skoltech professors and a Skoltech Ph.D. student, has presented Matcha, an AI-powered molecular docking model that performs virtual drug screening 30 times faster than the large ...
BACKGROUND: Despite antiplatelet therapy, some patients remain at high ischemic risk because of drug nonresponsiveness or high residual platelet reactivity). We aimed to target an orphan platelet GPCR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results